Why is Brivaracetam not recommended for patients to take at will?

Brivaracetam/Brivaracetam is an anti-epileptic drug approved by the FDA. It is mainly used to control partial seizures and related abnormal neurological discharges. Because its mechanism of action is different from traditional anti-epileptic drugs, it has the characteristics of rapid onset of action and few drug interactions, making it a new choice for many patients. However, clinical doctors generally emphasize that brivaracetam must not be taken at will or the dosage should be adjusted by oneself. The reason for this warning lies not only in pharmacological properties but also in the high sensitivity of the nervous system.

First, it is a prescription drug that acts on the central nervous system and targets synaptic vesicle protein 2A (SV2A). This protein plays a key role in neurotransmitter release. When the drug binds to SV2A, it can stabilize neuronal activity and suppress abnormal discharges. If the patient increases the dose on his own, although the symptoms may be relieved in the short term, the brain neurons will undergo adaptive changes due to excessive drug intervention, leading to drowsiness, decreased concentration, dizziness and even mood swings. Long-term irregular use may also lead to reduced efficacy or increased side effects.

Secondly, there are also risks if the patient reduces the dose or stops taking the medicine at will. The efficacy of Brivaracetam needs to be maintained at a stable blood concentration, and the brain's neural network also needs to be balanced in this state. Sudden reduction or skipping of medication may cause nerve firing activity to rebound rapidly, triggering new attacks. Some patients may even experience a more severe relapse than before, affecting their life and safety. Therefore, any dosage adjustment should be comprehensively evaluated by a physician based on condition, weight, and concomitant medications.

Another reason why casual use is not recommended is due to drug interactions. Although brivaracetam has a simpler metabolic pathway than other antiepileptic drugs, it may still be affected by liver metabolic enzymes. If the patient takes other drugs at the same time, such as antidepressants, sedatives or anti-infectives, the metabolism rate of brivaracetam may be changed, resulting in fluctuations in blood drug concentrations.

Reference materials:https://www.briviact.com/